Danish pharmaceutical giant Novo Nordisk and China’s leading internet healthcare provider Fangzhou have signed a Memorandum of Understanding (MoU) to collaborate on the management of serious chronic diseases, including diabetes and obesity.  

The partnership will combine Novo Nordisk’s global expertise and innovative products in diabetes and obesity treatment with Fangzhou’s smart healthcare ecosystem and robust technology infrastructure.

Together, they aim create a comprehensive health management service that offers medication guidance, reminders, efficacy tracking, and health education — transforming the value chain in the glucose control and weight loss sector.

This collaboration aims to shift the focus from a “disease-centered” approach to a “health-centered” model, providing patients with higher quality and more convenient one-stop healthcare services.

The MoU was signed at the 3rd China International Supply Chain Expo in Beijing between Dr. Xie Fangmin, Founder, Chairman, and CEO of Fangzhou, and Christine Zhou, Senior Vice President and President of Region China at Novo Nordisk.

Dr. Fangmin commented, “We are partnering with Novo Nordisk, a leading global healthcare company, to explore AI technology and address the pain points of traditional health management. Together, we aim to deliver innovative digital solutions for managing blood sugar and weight on a global scale.” 

Looking forward, both companies plan to explore further innovative collaborations in the medical industry’s digital transformation, with the goal of benefiting patients with serious chronic diseases and accelerating the achievement of the “Healthy China 2030” strategic objectives.  

“With the combined strengths of both companies, this collaboration will closely integrate chronic disease prevention and digital innovation technology, jointly enhancing public awareness of diabetes and obesity. It will also support the aim that the concepts of early screening, early diagnosis, and early treatment are effectively implemented within smart healthcare environments,” Zhou said.